Literature DB >> 26462769

[Chinese expert consensus on the diagnosis and treatment of primary myelofibrosis （2015)].

.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26462769     DOI： 10.3760/cma.j.issn.0253-2727.2015.09.001

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  6 in total

1.  [Chinese expert consensus on the diagnosis and treatment of eosinophilia (2017)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

2.  [Clinical features and risk factors of vein thrombosis in 259 patients with chronic myelofiberation neoplasms].

Authors:  M J Huang; Z P He; H Y Tian; Y Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

3.  Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia.

Authors:  Jinlian Che; Tianying Luo; Lan Huang; Qiyang Lu; Da Yan; Yinying Meng; Jinlan Xie; Weihua Chen; Jiangming Chen; Liling Long
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

4.  [Chinese guideline on the diagnosis and treatment of primary myelofibrosis (2019)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14

5.  [A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees].

Authors:  Z F Xu; T J Qin; H L Zhang; L W Fang; N B Hu; L J Pan; S Q Qu; B Li; X Yan; Z X Shi; H J Huang; D Liu; Y N Cai; Y D Zhang; P H Zhang; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14

6.  [Ruxolitinib combined with prednisone, thalidomide and danazol for treatment of myelofibrosis: a pilot study].

Authors:  Z F Xu; T J Qin; H L Zhang; L W Fang; L J Pan; N B Hu; S Q Qu; B Li; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.